Ask Warren

KoBioLabs

348150 · KOSDAQ · ₩348150 · 고바이오랩

₩2,720 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩22B₩19B₩15B₩19B₩18B₩17B₩18B₩17B
Cost of sales₩5.5B₩4.7B₩3.9B₩4.8B₩5.3B₩4.2B₩4.4B₩4.5B
Gross profit₩16B₩15B₩11B₩14B₩12B₩13B₩13B₩12B
Operating income−₩2B−₩2.7B−₩3B−₩423M−₩2.8B−₩3.5B−₩1.6B−₩1.3B
Net income−₩3.9B−₩195M−₩1.6B₩856M−₩3.2B−₩3.1B−₩1.1B−₩1.2B
Net income to shareholders−₩3.8B₩1.1M−₩1.1B₩128M−₩2.7B−₩2.6B−₩1.3B−₩1.6B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩92B₩91B₩91B₩94B₩92B₩97B₩102B₩104B
Current assets₩62B₩60B₩60B₩62B₩60B₩62B₩67B₩68B
Cash and equivalents₩15B₩7.1B₩4.6B₩6B₩7.9B₩6.1B₩5.7B₩7.9B
Total liabilities₩47B₩44B₩42B₩44B₩42B₩45B₩47B₩46B
Current liabilities₩18B₩15B₩13B₩13B₩12B₩9.3B₩14B₩15B
Borrowings₩16B₩16B₩13B₩13B₩13B₩15B₩16B₩16B
Total equity₩45B₩47B₩49B₩50B₩50B₩52B₩55B₩58B
Shareholders' equity₩29B₩30B₩32B₩33B₩34B₩35B₩38B₩41B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩748M−₩1B−₩712M₩23M−₩874M−₩4.2B−₩1.7B₩113M
Capital spending₩52M₩159M₩67M₩126M₩44M₩60M₩36M₩59M
Free cash flow−₩801M−₩1.2B−₩779M−₩103M−₩919M−₩4.3B−₩1.7B₩55M

Consolidated where available. Amounts in won.

Also known as: KoBioLabs / 고바이오랩 / 348150 / KRX:348150

Source: KRX statistical information